Evidence map›Paper›PMID 17938729›Full record

Trial reportEnvironmental health perspectives2007

Association between arsenic exposure from drinking water and plasma levels of soluble cell adhesion molecules.

Yu Chen, Regina M Santella, Muhammad G Kibriya, Qiao Wang, Maya Kappil, Wendy J Verret, Joseph H Graziano, Habibul Ahsan

Open access · diamondAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Environmental health perspectives, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed, 1 pooled it
3.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 1 synthesis or guideline pooled it, 75 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Yu ChenDepartments of Environmental Medicine and Medicine, and New York University Cancer Institute, New York University School of Medicine, New York, New York 10016, USA. Y.Chen@med.nyu.edu
Regina M Santella
Muhammad G Kibriya
Qiao Wang
Maya Kappil
Wendy J Verret
Joseph H Graziano
Habibul Ahsan
Columbia University · USUniversity of Chicago · USNew York University · USUniversity of California, Berkeley · US

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ADRIANA HEGUY · 1985 to 2026
$83.1M
Training CoreP42ES010349 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI NAVAS-ACIEN, ANA · 2000 to 2020
$53.6M
True Metal fac coreP30ES009089 · NIEHS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MATTHEW S PERZANOWSKI · 1998 to 2026
$44.7M
RESEARCH IN ENVIRONMENTAL HEALTH SCIENCES (CENTER GRANT)P30ES000260 · NIEHS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI COSTA, MAX · 1985 to 2020
$26.1M
Chemoprevention of arsenic-induced skin cancerR01CA107431 · NCI · UNIVERSITY OF CHICAGO · PI AHSAN, HABIBUL · 2005 to 2014
$17.3M
Genetic Susceptibility to Arsenic-induced Skin CancerR01CA102484 · NCI · UNIVERSITY OF CHICAGO · PI AHSAN, HABIBUL · 2004 to 2008
$2.0M
NCI NIH HHS CA016087NCI NIH HHS P30 CA016087NCI NIH HHS R01 CA102484NCI NIH HHS R01CA102484NCI NIH HHS R01 CA107431NCI NIH HHS R01CA107431NIEHS NIH HHS ES00026NIEHS NIH HHS P30 ES000260NIEHS NIH HHS P30 ES009089NIEHS NIH HHS P30ES09089NIEHS NIH HHS P42 ES010349NIEHS NIH HHS P42ES10349
6 · The paper itself

Abstract

backgroundEpidemiologic studies of cardiovascular disease risk factors and appropriate biomarkers in populations exposed to a wide range of arsenic levels are a public health research priority.

objectiveWe investigated the relationship between inorganic arsenic exposure from drinking water and plasma levels of soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular adhesion molecule-1 (sVCAM-1), both markers of endothelial dysfunction and vascular inflammation, in an arsenic-exposed population in Araihazar, Bangladesh.

methodsThe study participants included 115 individuals with arsenic-related skin lesions participating in a 2 x 2 randomized, placebo-controlled, double-blind trial of vitamin E and selenium supplementation. Arsenic exposure status and plasma levels of sICAM-1 and sVCAM-1 were assessed at baseline and after 6 months of follow-up.

resultsBaseline well arsenic, a long-term measure of arsenic exposure, was positively associated with baseline levels of both sICAM-1 and sVCAM-1 and with changes in the two markers over time. At baseline, for every 1-mug/L increase in well arsenic there was an increase of 0.10 ng/mL [95% confidence interval (CI), 0.00-0.20] and 0.33 ng/mL (95% CI, 0.15-0.51) in plasma sICAM-1 and sVCAM-1, respectively. Every 1-microg/L increase in well arsenic was associated with a rise of 0.11 ng/mL (95% CI, 0.01-0.22) and 0.17 ng/mL (95% CI, 0.00-0.35) in sICAM-1 and sVCAM-1 from baseline to follow-up, respectively, in spite of recent changes in urinary arsenic as well as vitamin E and selenium supplementation during the study period.

conclusionsThe findings indicate an effect of chronic arsenic exposure from drinking water on vascular inflammation that persists over time and also suggest a potential mechanism underlying the association between arsenic exposure and cardiovascular disease.

Indexed as

Environmental ExposureAdultArsenicArsenic PoisoningBangladeshBiomarkersCardiovascular DiseasesEpidemiologic StudiesFemaleHumansInflammationIntercellular Adhesion Molecule-1MaleMiddle AgedProspective StudiesVascular Cell Adhesion Molecule-1ArsenicBiomarkersIntercellular Adhesion Molecule-1Vascular Cell Adhesion Molecule-1Water Pollutants, ChemicalarsenicBangladeshcardiovascular diseaseendothelial dysfunctionenvironmental epidemiologyepidemiologyvascular inflammation

Identifiers

PMID17938729
PMCPMC2022642
OpenAlexW1971113341

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.